肾细胞癌孤立性对侧肾上腺转移:68Ga-DOTATATE PET/CT表现
本文报道一例55岁女性,2年前因左肾透明细胞癌行左肾切除术,因评估肾上腺肿块行68Ga-DOTATATE PET/CT,显示肾上腺肿块呈强烈68Ga-DOTATATE摄取,病理证实为透明细胞肾细胞癌转移。提示68Ga-DOTATATE PET/CT可用于肾细胞癌随访监测。
要点
- 肾细胞癌表达生长抑素受体,68Ga-DOTATATE PET/CT可用于其随访监测。
- 本例肾上腺肿块呈强烈68Ga-DOTATATE摄取,病理证实为透明细胞肾细胞癌转移。
- 既往报道显示肾细胞癌转移灶68Ga-DOTATATE摄取的病例有限。
核心结论
- 68Ga-DOTATATE PET/CT可显示肾细胞癌肾上腺转移灶的强烈摄取,并可用于肾细胞癌随访监测。
研究设计与样本
- 本文为病例报告,报道一例55岁女性,2年前因左肾透明细胞癌行左肾切除术,因评估肾上腺肿块行68Ga-DOTATATE PET/CT。
主要发现
- 68Ga-DOTATATE PET/CT显示肾上腺肿块呈强烈68Ga-DOTATATE摄取。
- 肾上腺肿块组织病理学证实为透明细胞肾细胞癌转移。
临床怎么用
- 在肾细胞癌随访中,可考虑应用68Ga-DOTATATE PET/CT评估可疑转移灶。
局限性
- 既往报道显示肾细胞癌转移灶68Ga-DOTATATE摄取的病例有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
68Ga-DOTATATE PET/CT is an imaging technique used in the diagnosis of neuroendocrine tumors. Since renal cell carcinoma (RCC) expresses the somatostatin receptors, 68Ga-DOTATATE PET/CT could be used in the surveillance of RCC. However, limited cases showing 68Ga-DOTATATE uptake in the metastases of RCC have been reported before. Herein, we report a case of a 55-year-old woman with a history of left nephrectomy for clear cell renal cell carcinoma 2 years before, and referred to 68Ga-DOTATATE PET/CT for the evaluation of adrenal mass. 68Ga-DOTATATE PET/CT showed intense 68Ga-DOTATATE uptake on the adrenal mass. Histopathology of the adrenal mass confirmed the diagnosis of clear cell renal cell carcinoma metastasis.
引用
- Filizoglu N, Ozguven S. Solitary Contralateral Adrenal Metastasis of Renal Cell Carcinoma: 68Ga-DOTATATE PET/CT Findings. Clin Nucl Med. 2022. PMID: 34132679. doi:10.1097/RLU.0000000000003775
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。